Tenet Healthcare (NYSE:THC) Releases FY 2025 Earnings Guidance

Tenet Healthcare (NYSE:THC) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 11.740-12.840 for the period, compared to the consensus estimate of 11.080. The company issued revenue guidance of $20.6 billion-$21.0 billion, compared to the consensus revenue estimate of $21.3 billion.

Tenet Healthcare Stock Down 0.7 %

Tenet Healthcare stock opened at $138.52 on Wednesday. The company has a market capitalization of $13.17 billion, a P/E ratio of 4.44, a P/E/G ratio of 0.63 and a beta of 2.05. The firm’s fifty day simple moving average is $133.85 and its 200-day simple moving average is $148.52. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 2.35. Tenet Healthcare has a 1-year low of $86.90 and a 1-year high of $171.20.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on THC shares. KeyCorp cut their price target on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Barclays raised their target price on shares of Tenet Healthcare from $171.00 to $190.00 and gave the company an “overweight” rating in a research note on Friday, November 8th. Raymond James lowered shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 target price on the stock. in a research note on Friday, November 22nd. JPMorgan Chase & Co. reiterated an “overweight” rating and issued a $175.00 target price on shares of Tenet Healthcare in a research note on Tuesday, December 17th. Finally, Truist Financial lowered their target price on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Three investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Tenet Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $165.00.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.